Radiopharm Theranostics Limited
RDPTF
$0.0113
$0.01051,312.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 450.80K | 463.60K | 98.60K | 98.40K | -- |
| Total Other Revenue | 343.30K | 353.00K | -792.70K | -791.10K | 1.32M |
| Total Revenue | 794.10K | 816.60K | -694.20K | -692.70K | 1.32M |
| Cost of Revenue | 4.96M | 5.10M | 2.14M | 2.14M | 4.92M |
| Gross Profit | -4.16M | -4.28M | -2.84M | -2.83M | -3.60M |
| SG&A Expenses | 2.29M | 2.36M | 2.52M | 2.51M | 2.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.25M | 7.45M | 4.66M | 4.65M | 7.54M |
| Operating Income | -6.45M | -6.64M | -5.36M | -5.35M | -6.21M |
| Income Before Tax | -6.37M | -6.55M | -7.62M | -7.60M | -8.06M |
| Income Tax Expenses | 32.90K | 33.80K | 21.50K | 21.40K | 10.20K |
| Earnings from Continuing Operations | -6.40M | -6.58M | -7.64M | -7.63M | -8.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 299.00K | 307.40K | -- | -- | 354.00K |
| Net Income | -6.10M | -6.27M | -7.64M | -7.63M | -7.71M |
| EBIT | -6.45M | -6.64M | -5.36M | -5.35M | -6.21M |
| EBITDA | -5.96M | -6.13M | -4.85M | -4.84M | -5.70M |
| EPS Basic | 0.00 | 0.00 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.84B | 1.84B | 429.64M | 429.64M | 328.32M |
| Average Diluted Shares Outstanding | 1.84B | 1.84B | 429.64M | 429.64M | 328.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
